Volume 2 Issue 2

Opinion Piece

Why Lesotho Should Speed up and Invest in sustainable Women's Prevention, as Part of HIV Combination Prevention Strategy

Lepheana P Mosooane*

Women are still Vulnerable to Men and in Need of Tools to Protect Themselves from HIV. The Good News is there are New Prevention Methods, Initiated and Controlled by Women, on their Way. We Need Advocacy to Speed up their Arrival. PDF

Research Article

Gender Power Inequalities in the Context of HIV/AIDS among South African Indians in an Urban Setting in Kwazulu-Natal, South Africa

Dhee Naidoo1,2*, Myra Taylor2 and Musawenkosi LH Mabaso1

A lot of studies on gender power dynamics in relation to HIV in South Africa focus on the high risk African Black population, and little attention has been given to the minority groups. Similar to other communities in the country PDF

Research Article

Biological Characteristics as a Determining Factor in Evaluating the Efficacy of DOTS in MDR Tb Treatment

Nicole Fogel*

Mycobacterium Tuberculosis (MTB) drug resistance (DR) is a manmade amplification of selective pressures of genetic mutants that result from spontaneous chromosomal mutations due to poor treatment methods, despite the WHO guidelines and enforcement. MDR TB rates are higher than ever (up to 22.3% in some countries) and extensively DR, (XDR) TB has been reported PDF

Research Article

CD1e Genotype Pilot Study of Cytokine Production and T-Cell Proliferation: A Novel Relationship Between in Vitro Immune Function and CD1e Polymorphism in Brazilians

Felipe Souza Duque1 , Frank Sotzik2*, Gregory J.S. Tan3 , Silvana Gaudieri4 and Luis Filgueira5

The MHC class I-like CD1a-e molecules have a processing and presentation role for lipid and glycolipid antigens of self and micro-organisms such as mycobacteria. In this pilot study, CD1e polymorphisms were determined by sequencing exons 2 and 3, for eight Brazilians PDF